Anggot, Gregorio .
HRN: 01-24-46 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/26/2025
LEVOFLOXACIN 500MG (TAB)
05/26/2025
06/02/2025
PO
500MG
OD
PNEUMONIA
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes